Varex Imaging Corporation
Varex Imaging Corporation
VREX
Valuace
78
Růst
48
Zdraví
82
Cena
$ 12.09
Dnes
--0.07 (-0.51%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.5B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-7
PS
1
Cena 1R
7-15
⌀ Cena
10.11
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
10-02-2026
Poslední dividenda

Profil

Společnost Varex Imaging Corporation navrhuje a vyrábí součásti pro rentgenové zobrazování. Společnost působí ve dvou segmentech, a to v oblasti medicíny a průmyslu. Lékařský segment navrhuje, vyrábí, prodává a servisuje rentgenové zobrazovací komponenty, které zahrnují rentgenové trubice, digitální detektory, vysokonapěťové konektory, software a pracovní stanice pro zpracování obrazu, 3D rekonstrukci a počítačově podporovaný diagnostický software, kolimátory, zařízení pro automatickou kontrolu expozice, generátory, výměníky tepla, ionizační komory a přezky. Produkty tohoto segmentu se používají v řadě aplikací, včetně radiografického a fluoroskopického zobrazování, mamografie, počítačové tomografie, radiační terapie, onkologie, CT, srdeční, chirurgické, zubní, počítačem podporované detekce a dalších diagnostických radiografických použití. Průmyslový segment navrhuje, vyrábí, prodává a poskytuje služby Linatron Rentgenové urychlovače, rentgenové trubice, digitální detektory a vysokonapěťové konektory pro použití v bezpečnostních a průmyslových inspekčních aplikacích, jako je bezpečnost letišť, detekční kontrola nákladu v přístavech a na hranicích a nedestruktivní testování a kontrola v různých aplikacích. Společnost Varex Imaging Corporation prodává své produkty prostřednictvím výrobců originálních zařízení zobrazovacích systémů, nezávislých servisních společností a distributorů a také přímo koncovým uživatelům. Společnost působí v Severní Americe, Jižní Americe, Evropě, Rusku, na Blízkém východě, v Indii, Africe, Asii a Austrálii. Společnost Varex Imaging Corporation byla založena v roce 2016 a sídlí v Salt Lake City v Utahu.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
2300
Založení
2017-01-23
Adresa
1678 South Pioneer Road
CEO
Sunny S. Sanyal

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013
Total Revenues854.4844.6811.0893.4859.4818.1738.3780.6773.4698.1620.1632.3685.2669.8
Cost of Revenues562.6554.1554.1603.1575.9546.6548.1523.9519.5444.6371.7381.7406.6401.7
Gross Profit291.8290.5256.9290.3283.5271.5190.2256.7253.9253.5248.4250.6278.6268.1
Revenue 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Total Revenues209.6228.9203.0212.9199.8205.7209.1206.2190.0227.4
Cost of Revenues139.8151.1135.5136.2131.3138.6142.2140.4132.9149.4
Gross Profit69.877.867.576.768.567.166.965.857.178.0
Operating Income TTM 2025202420232022202120202019201820172016201520142013
R&D Expenses0.00.00.084.877.071.978.978.183.067.353.550.440.035.9
Selling General & Admin Expenses0.00.00.0128.4118.3125.5142.2128.1126.4102.585.872.762.663.4
Depreciation & Amortization26.927.231.133.233.637.3-6.739.242.227.415.312.310.110.1
Total Operating Expenses315.4318.3224.8213.2195.3197.4221.1206.2209.4169.8139.3123.1102.699.3
Operating Income-23.6-27.832.177.150.733.4-30.98.244.583.7109.1127.5176.0168.8
Operating Income TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
R&D Expenses0.00.00.00.00.00.00.00.00.021.8
Selling General & Admin Expenses0.00.00.00.00.00.00.00.00.031.9
Depreciation & Amortization6.86.76.86.67.16.67.08.88.78.8
Total Operating Expenses54.458.2148.254.657.356.257.658.152.953.7
Operating Income15.419.6-80.722.111.210.99.37.74.224.3
Net Income TTM 2025202420232022202120202019201820172016201520142013
Interest Income7.08.57.33.70.40.10.10.10.20.20.30.50.30.2
Interest Expense35.235.531.129.339.842.131.421.121.712.31.91.20.90.4
Other Expense-34.3-31.4-27.1-45.8-6.2-4.8-40.913.32.73.2-2.50.8-1.22.7
IBT-57.9-59.25.031.344.528.6-71.821.525.774.8105.0127.6174.2171.3
Income Tax Expense9.510.752.2-17.413.710.7-15.25.7-2.622.836.046.864.161.7
Net Income-67.7-70.3-47.748.230.317.4-56.615.527.551.668.580.0110.1109.6
Net Income TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Interest Income0.61.02.52.92.11.81.81.81.91.6
Interest Expense7.97.99.010.48.27.87.68.14.67.2
Other Expense-11.6-5.5-5.9-11.3-8.7-8.4-8.5-5.4-4.8-23.3
IBT3.814.1-86.610.82.52.50.82.3-0.61.0
Income Tax Expense1.41.92.53.72.652.4-0.70.7-0.2-31.0
Net Income2.312.2-89.16.9-0.3-50.01.41.4-0.531.9
Per Share Data TTM 2025202420232022202120202019201820172016201520142013
EPS$0.00$0.00$0.00$1.20$0.76$0.44$-1.46$0.41$0.73$1.37$1.79$2.09$2.88$2.87
EPS Diluted$0.00$0.00$0.00$0.96$0.73$0.43$-1.46$0.40$0.72$1.36$1.78$2.08$2.87$2.85
Shares Outstanding41.841.440.840.339.839.338.838.237.937.638.238.238.238.2
Diluted Shares Outstanding42.341.440.850.341.640.338.838.638.438.038.438.438.438.4
Per Share Data TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.79
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.63
Shares Outstanding41.841.641.541.441.140.840.940.740.640.4
Diluted Shares Outstanding42.341.841.551.241.140.841.241.240.650.5
Current Assets TTM 20242023202220212020201920182017201620152014
Cash And Equivalents156.4168.7152.689.4144.6100.629.951.983.336.520.60.5
Short Term Investments33.631.841.30.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments190.0200.5152.689.4144.6100.629.951.983.336.520.60.5
Accounts Receivable152.7157.7163.6173.3155.3123.8141.0154.0163.6122.2117.8128.7
Inventory281.7264.8277.5303.2224.8271.9250.3235.1234.5197.4174.9139.6
Other Current Assets24.926.964.644.029.525.719.117.113.93.82.81.8
Total Current Assets649.3649.9658.3609.9554.2522.0440.3458.1495.3359.9316.1270.6
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents136.4205.1176.0168.7156.4141.8141.3152.6118.5104.4
Short Term Investments16.217.936.631.833.647.152.241.333.513.7
Total Cash & ST Investments152.6223.0212.6200.5190.0188.9193.5152.6118.5104.4
Accounts Receivable137.0145.7138.1157.7152.0152.2139.6163.6163.3159.5
Inventory298.7284.7279.9264.8281.7286.1289.7277.5297.7310.7
Other Current Assets31.230.426.326.925.624.722.964.659.086.6
Total Current Assets619.5683.8656.9649.9649.3651.9645.7658.3638.5618.4
Long-Term Assets TTM 20242023202220212020201920182017201620152014
Net Property, Plant & Equipment176.5181.7172.6164.5164.5172.9142.3144.9148.3108.996.263.0
Goodwill288.9291.0288.5284.5292.2293.1290.8243.6241.974.774.736.0
Intangible Assets16.416.122.433.650.767.586.373.891.320.724.04.7
Long-Term Investments28.526.829.046.449.351.353.651.052.349.358.749.7
Other Long-Term Assets37.846.837.543.232.632.227.5-6.1-18.53.43.40.0
Total Long-Term Assets603.4567.1591.3574.5593.3617.5600.5530.4544.8262.5267.5162.5
Total Assets1,252.71,217.01,249.61,184.41,147.51,139.51,040.8988.51,040.1622.4583.6433.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment176.7177.6178.2181.7176.5177.2176.7172.6170.7165.8
Goodwill198.5290.3287.2291.0288.9289.3290.4288.5289.2289.2
Intangible Assets15.015.314.216.116.418.222.122.425.528.9
Long-Term Investments24.623.225.226.827.130.328.329.046.847.3
Other Long-Term Assets36.1164.4167.446.839.237.037.137.538.239.1
Total Long-Term Assets453.9673.8675.3567.1603.4599.8596.6591.3573.2572.4
Total Assets1,073.41,357.61,332.21,217.01,252.71,251.71,242.31,249.61,211.71,190.8
Current Liabilities TTM 20242023202220212020201920182017201620152014
Accounts Payable69.659.164.778.258.872.960.966.358.941.949.741.8
Short-Term Debt50.150.35.36.19.08.630.725.020.00.21.20.0
Other Current Liabilities66.870.558.581.489.770.573.048.162.423.718.423.1
Current Liabilities194.6195.9162.8173.1166.6160.6175.1152.6151.877.878.668.8
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable70.770.865.659.169.669.473.764.774.674.2
Short-Term Debt5.85.78.850.350.15.55.45.45.25.9
Other Current Liabilities85.682.666.770.566.869.261.679.468.067.0
Current Liabilities176.7168.8150.5195.9194.6154.1150.1162.8158.6157.2
Long-Term Liabilities TTM 20242023202220212020201920182017201620152014
Long-Term Debt396.9420.1464.4430.3450.4475.9364.4364.8463.90.00.00.0
Capital Leases23.327.026.922.024.929.20.00.00.00.00.00.0
Def. Tax Liability0.01.40.00.52.22.39.023.229.53.03.80.0
Total Liabilities657.4667.8668.6637.7651.0673.7581.0549.1649.986.188.073.8
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt44.5591.1592.8420.1420.2465.9464.3464.4464.5458.1
Capital Leases23.323.525.127.026.524.526.726.926.821.0
Def. Tax Liability2.60.00.01.40.00.00.0-21.70.00.0
Total Liabilities603.9793.7778.0667.8657.4661.5659.3668.6666.8657.9
Total Common Equity TTM 20242023202220212020201920182017201620152014
Common Stock0.40.40.40.40.40.40.40.40.40.00.00.0
Retained Earnings120.470.4118.163.833.516.975.562.435.10.00.00.0
Comprehensive Income-1.8-2.9-1.20.10.00.0-1.75.80.80.0-0.10.0
Total Common Equity581.2535.1567.7533.4483.3451.7446.0426.2379.0526.0484.6359.3
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.40.40.40.40.40.40.40.40.4
Retained Earnings-18.177.070.170.4120.4119.0117.5118.186.577.4
Comprehensive Income-5.4-2.4-0.3-2.9-1.8-1.7-2.2-1.2-0.30.2
Total Common Equity455.3549.7540.2535.1581.2576.1568.9567.7531.5519.6
Other TTM 20242023202220212020201920182017201620152014
Total Debt470.3470.4469.5436.4459.4484.5395.1389.8483.90.00.00.0
Book Value595.3549.2581.0546.7496.5465.8459.8439.4390.2536.3495.6359.3
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt14.214.214.014.114.114.114.113.313.413.3
Book Value455.3549.7540.2535.1581.2576.1568.9567.7531.5519.6
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013
Net Income34.4-69.9-47.248.730.817.9-57.415.828.352.069.080.8110.1109.6
Depreciation & Amortization33.327.231.133.233.637.339.539.242.227.415.312.310.110.1
Stock-Based Compensation15.215.015.313.514.013.913.411.710.08.49.59.68.09.8
Change Working Capital10.6-31.42.023.3-88.08.2-13.94.76.0-6.6-26.2-15.1-8.2-31.0
Change In Accounts Receivable12.00.16.79.8-18.1-32.917.714.89.0-23.1-4.619.3-9.0-11.8
Change In Accounts Payable-4.46.2-3.2-15.019.7-13.614.3-9.05.24.9-1.9-4.34.411.8
Change In Inventories10.5-39.96.620.2-85.042.8-42.7-11.1-2.4-4.2-23.5-25.9-4.3-32.4
Other Non-cash Items75.0101.39.129.225.918.334.713.46.52.32.4-1.60.1-5.7
Cash from Operations66.30.00.0108.416.992.613.271.985.374.674.285.2118.691.2
Cash Flow From Operating Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Income2.312.2-89.17.1-0.1-50.01.41.4-0.432.0
Depreciation & Amortization6.86.76.86.67.16.67.08.88.78.8
Stock-Based Compensation3.83.43.73.84.13.53.94.23.73.4
Change Working Capital-35.0-16.5-3.5-4.8-6.611.5-0.4-9.60.520.1
Change In Accounts Receivable8.9-20.18.6-7.919.5-5.7-0.6-12.325.3-0.4
Change In Accounts Payable12.1-5.40.04.86.8-10.1-0.2-1.99.0-11.3
Change In Inventories-30.1-2.3-16.5-5.5-15.614.63.81.4-13.218.5
Other Non-cash Items5.4-0.693.23.84.92.93.84.1-1.421.2
Cash from Operations0.00.00.00.00.00.00.00.00.047.1
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013
Capital Expenditure-26.3-22.9-26.9-20.7-21.3-15.1-23.5-19.8-20.4-20.2-28.9-34.3-23.2-8.3
Acquisitions-0.10.00.9-1.01.1-1.4-3.4-73.4-4.8-271.8-1.2-67.9-5.40.0
Investments-56.9-31.4-61.0-55.9-28.30.00.00.00.00.00.00.00.00.0
Sales of Investment56.865.460.635.32.00.00.00.00.00.08.60.00.00.0
Other Investing Activities-1.60.00.0-2.6-1.90.30.00.0-0.60.0-0.10.10.00.0
Cash from Investing-28.10.00.0-44.9-48.4-16.2-26.9-93.2-25.8-292.0-21.6-102.1-28.6-8.3
Cash Flow From Investing Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Capital Expenditure-10.7-5.6-6.3-6.8-4.2-6.0-4.7-5.8-10.4-5.4
Acquisitions0.00.00.00.00.00.00.00.00.9-1.0
Investments0.0-0.80.0-9.2-21.4-23.7-2.2-10.6-24.5-19.6
Sales of Investment4.06.24.830.923.515.415.016.014.211.6
Other Investing Activities0.00.00.00.00.00.00.00.00.0-0.2
Cash from Investing0.00.00.00.00.00.00.00.00.0-14.6
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013
Debt Repaid-1.90.00.0-2.4-29.4-33.1-483.9-87.0-106.0-255.00.00.00.00.0
Debt Issued2.5470.40.935.56.48.0573.392.311.9738.90.00.00.00.0
Issuance of Common Stock4.10.00.04.13.80.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock-1.90.00.0-1.40.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.0-0.5-0.60.00.00.00.00.0
Other Financing Activities0.40.00.02.21.80.8567.587.416.2518.3-36.836.7-89.9-83.3
Cash from Financing-0.50.00.0-0.2-23.8-32.383.6-0.1-90.4263.3-36.836.7-89.9-83.3
Cash Flow From Financing Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Debt Repaid0.00.00.00.00.00.00.00.00.0-0.7
Debt Issued0.024.8-572.0-4.8131.20.1-1.11.70.20.5
Issuance of Common Stock0.00.00.00.00.00.00.00.00.02.1
Repurchase of Common Stock-1.50.00.00.00.0-0.30.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.02.1
Cash from Financing0.00.00.00.00.00.00.00.00.01.4
Cash position TTM 2025202420232022202120202019201820172016201520142013
Net Change in Cash37.9-23.316.463.4-55.544.070.8-22.1-31.446.815.920.10.1-0.4
Closing Cash Balance156.4147.1170.4154.090.6146.1102.131.351.983.336.520.60.50.4
Cash position 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Change in Cash-25.48.6-193.730.4131.412.614.60.5-11.334.1
Closing Cash Balance121.7147.1138.5332.2301.8170.4157.8143.2142.7154.0
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013
Free Cash Flow40.018.820.487.7-4.477.5-10.352.164.954.445.350.995.482.9
Real Free Cash Flow24.83.85.174.2-18.463.6-23.740.454.946.035.841.387.473.1
Free Cash Flow 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Free Cash Flow-26.82.31.49.85.319.93.3-2.7-0.141.7
Real Free Cash Flow-30.6-1.1-2.36.01.216.4-0.6-6.9-3.838.3
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-6.730.7179.3
P/S0.51.2390.6
P/B12113.4
P/FCF-16.1-558149.9
Market cap$0.5$0.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %31.4 %0 %
Debt to Income-36.6 %987.7 %0 %
Debt to Free cash flow-88.6 %7.6 %0 %
Interest expense percentage-149.2 %4.5 %11.2 %
Current ratio3.5 3.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-14.9 %2.8 %0 %
ROA-6.3 %1.6 %0 %
CapEx to Revenue3.4 %3.4 %6 %
RaD to Revenue0 %9.1 %0 %
ROEM356,000.0 288435.9

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin34.2 %33.5 %61.9 %
Operating margin-2.8 %7.1 %17.9 %
Net margin-7.9 %2 %13 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0.9 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding42.3 mil 40.5 mil
Employee count2.4 tis 2.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader